Endocannabinoids and Their Role in Fatty Liver Disease

Publisher： Karger

E-ISSN： 1421-9875|28|1|261-266

ISSN： 0257-2753

Source： Digestive Diseases, Vol.28, Iss.1, 2010-05, pp. : 261-266

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Cytokines in Non-Alcoholic Fatty Liver Disease

Digestive Diseases, Vol. 28, Iss. 1, 2010-05 ,pp. : 179-185

Karger

Access to resources Recommend Favorite

The Role of Non-Alcoholic Fatty Liver Disease in Cardiovascular Disease

Digestive Diseases, Vol. 28, Iss. 1, 2010-05 ,pp. : 210-213

Karger

Access to resources Recommend Favorite

Protective Role of Coffee in Non-alcoholic Fatty Liver Disease (NAFLD)

By Catalano Daniela Martines Giuseppe Tonzuso Antonia Pirri Clara Trovato Francesca Trovato Guglielmo

Digestive Diseases and Sciences, Vol. 55, Iss. 11, 2010-11 ,pp. : 3200-3206

Springer Publishing Company

Access to resources Recommend Favorite

The Role of a Dedicated Non-Alcoholic Fatty Liver Disease Clinic in 2016

Digestive Diseases, Vol. 35, Iss. 4, 2017-05 ,pp. : 371-376

Karger

Access to resources Recommend Favorite

Non-alcoholic fatty liver disease

By Björnsson Einar Angulo Paul

Scandinavian Journal of Gastroenterology, Vol. 42, Iss. 9, 2007-01 ,pp. : 1023-1030

Informa Healthcare

Access to resources Recommend Favorite